Artal Group’s Neumora Therapeutics NMRA Stock Holding History

Artal Group’s Portfolio NMRA Stock Details NMRA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$27.8M	Sell
2024 Q1	$40.2M	Buy
2023 Q4	$43.5M	Sell
2023 Q3	$39.5M	Buy